APO Research
Talk to an analyst

APO RESEARCH · REPORT

Donepezil Hydrochloride Tablets

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Donepezil Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchDonepezil Hydrochloride Tablets Industry Research Report 2026143 pages · $2,950 USDIndustry Growth & TrendsGlobal Donepezil Hydrochloride Tablets Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Donepezil Hydrochloride Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Donepezil Hydrochloride Tablets Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Donepezil Hydrochloride Tablets Market Analysis and Forecast 2026-2032210 pages · $4,950 USD

Market perspective

The global Donepezil Hydrochloride Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Donepezil Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Donepezil Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Donepezil Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Donepezil Hydrochloride Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Donepezil Hydrochloride Tablets include Zein Biotechnology, Zhejiang Huahai Pharmaceutical, Yangtze River Pharmaceutical, Tianjin Lisheng Pharmaceutical, Sichuan Sunnyhope Pharmaceutical, Shaanxi Ark Pharmaceutical, Shandong Fangming Pharmaceutical, Goldensun Pharmaceutical and Hansoh Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Donepezil Hydrochloride Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Donepezil Hydrochloride Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Donepezil Hydrochloride Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Donepezil Hydrochloride Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Donepezil Hydrochloride Tablets Segment by Company

Zein Biotechnology

Zhejiang Huahai Pharmaceutical

Yangtze River Pharmaceutical

Tianjin Lisheng Pharmaceutical

Sichuan Sunnyhope Pharmaceutical

Shaanxi Ark Pharmaceutical

Shandong Fangming Pharmaceutical

Goldensun Pharmaceutical

Hansoh Pharma

Hisun Pharmaceuticals

Furen Medicines

Disha Pharmaceutical

Zydus

Torrent Pharmaceuticals

Strides Pharma

Macleods Pharmaceuticals

Lupin

Hetero

Eisai

Dr. Reddy's Laboratories

Cipla

Chartwell

Cadila Pharmaceuticals

Aurobindo Pharma

Alembic

Donepezil Hydrochloride Tablets Segment by Type

Orally Disintegrating Tablets

Immediate-release Tablets

Donepezil Hydrochloride Tablets Segment by Application

Retail Pharmacy

Hospital Pharmacy

Online Pharmacy

Donepezil Hydrochloride Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Donepezil Hydrochloride Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Donepezil Hydrochloride Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Donepezil Hydrochloride Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Donepezil Hydrochloride Tablets market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Donepezil Hydrochloride Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Donepezil Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Donepezil Hydrochloride Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Donepezil Hydrochloride Tablets Industry Trends Table 2. Donepezil Hydrochloride Tablets Industry Drivers Table 3. Donepezil Hydrochloride Tablets Industry Opportunities and Challenges Table 4. Donepezil Hydrochloride Tablets Industry Restraints Table 5. Global Donepezil Hydrochloride Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Donepezil Hydrochloride Tablets Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Donepezil Hydrochloride Tablets Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Donepezil Hydrochloride Tablets Sales Market Share by Manufacturers Table 9. Global Donepezil Hydrochloride Tablets Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Donepezil Hydrochloride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Donepezil Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Donepezil Hydrochloride Tablets Manufacturers, Product Type & Application Table 13. Global Donepezil Hydrochloride Tablets Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Donepezil Hydrochloride Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Orally Disintegrating Tablets Table 17. Major Manufacturers of Immediate-release Tablets Table 18. Global Donepezil Hydrochloride Tablets Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Donepezil Hydrochloride Tablets Sales by Type (2021-2026) & (K Units) Table 20. Global Donepezil Hydrochloride Tablets Sales by Type (2027-2032) & (K Units) Table 21. Global Donepezil Hydrochloride Tablets Sales Market Share by Type (2021-2026) Table 22. Global Donepezil Hydrochloride Tablets Sales Market Share by Type (2027-2032) Table 23. Global Donepezil Hydrochloride Tablets Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Donepezil Hydrochloride Tablets Revenue by Type (2021-2026) & (K Units) Table 25. Global Donepezil Hydrochloride Tablets Revenue by Type (2027-2032) & (K Units) Table 26. Global Donepezil Hydrochloride Tablets Revenue Market Share by Type (2021-2026) Table 27. Global Donepezil Hydrochloride Tablets Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacy Table 29. Major Manufacturers of Hospital Pharmacy Table 30. Major Manufacturers of Online Pharmacy Table 31. Global Donepezil Hydrochloride Tablets Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Donepezil Hydrochloride Tablets Sales by Application (2021-2026) & (K Units) Table 33. Global Donepezil Hydrochloride Tablets Sales by Application (2027-2032) & (K Units) Table 34. Global Donepezil Hydrochloride Tablets Sales Market Share by Application (2021-2026) Table 35. Global Donepezil Hydrochloride Tablets Sales Market Share by Application (2027-2032) Table 36. Global Donepezil Hydrochloride Tablets Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Donepezil Hydrochloride Tablets Revenue by Application (2021-2026) & (K Units) Table 38. Global Donepezil Hydrochloride Tablets Revenue by Application (2027-2032) & (K Units) Table 39. Global Donepezil Hydrochloride Tablets Revenue Market Share by Application (2021-2026) Table 40. Global Donepezil Hydrochloride Tablets Revenue Market Share by Application (2027-2032) Table 41. Global Donepezil Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Donepezil Hydrochloride Tablets Sales by Region (2021-2026) & (K Units) Table 43. Global Donepezil Hydrochloride Tablets Sales Market Share by Region (2021-2026) Table 44. Global Donepezil Hydrochloride Tablets Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Donepezil Hydrochloride Tablets Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Donepezil Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Donepezil Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 48. North America Donepezil Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 49. Europe Donepezil Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Donepezil Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 51. Europe Donepezil Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Donepezil Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Donepezil Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Donepezil Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Donepezil Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Donepezil Hydrochloride Tablets Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Donepezil Hydrochloride Tablets Sales by Country (2027-2032) & (K Units) Table 58. Global Donepezil Hydrochloride Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Donepezil Hydrochloride Tablets Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Donepezil Hydrochloride Tablets Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Donepezil Hydrochloride Tablets Revenue Market Share by Region (2021-2026) Table 62. Global Donepezil Hydrochloride Tablets Revenue Market Share by Region (2027-2032) Table 63. Zein Biotechnology Company Information Table 64. Zein Biotechnology Business Overview Table 65. Zein Biotechnology Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zein Biotechnology Donepezil Hydrochloride Tablets Product Portfolio Table 67. Zein Biotechnology Recent Development Table 68. Zhejiang Huahai Pharmaceutical Company Information Table 69. Zhejiang Huahai Pharmaceutical Business Overview Table 70. Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 72. Zhejiang Huahai Pharmaceutical Recent Development Table 73. Yangtze River Pharmaceutical Company Information Table 74. Yangtze River Pharmaceutical Business Overview Table 75. Yangtze River Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Yangtze River Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 77. Yangtze River Pharmaceutical Recent Development Table 78. Tianjin Lisheng Pharmaceutical Company Information Table 79. Tianjin Lisheng Pharmaceutical Business Overview Table 80. Tianjin Lisheng Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Tianjin Lisheng Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 82. Tianjin Lisheng Pharmaceutical Recent Development Table 83. Sichuan Sunnyhope Pharmaceutical Company Information Table 84. Sichuan Sunnyhope Pharmaceutical Business Overview Table 85. Sichuan Sunnyhope Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sichuan Sunnyhope Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 87. Sichuan Sunnyhope Pharmaceutical Recent Development Table 88. Shaanxi Ark Pharmaceutical Company Information Table 89. Shaanxi Ark Pharmaceutical Business Overview Table 90. Shaanxi Ark Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shaanxi Ark Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 92. Shaanxi Ark Pharmaceutical Recent Development Table 93. Shandong Fangming Pharmaceutical Company Information Table 94. Shandong Fangming Pharmaceutical Business Overview Table 95. Shandong Fangming Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Shandong Fangming Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 97. Shandong Fangming Pharmaceutical Recent Development Table 98. Goldensun Pharmaceutical Company Information Table 99. Goldensun Pharmaceutical Business Overview Table 100. Goldensun Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Goldensun Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 102. Goldensun Pharmaceutical Recent Development Table 103. Hansoh Pharma Company Information Table 104. Hansoh Pharma Business Overview Table 105. Hansoh Pharma Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Hansoh Pharma Donepezil Hydrochloride Tablets Product Portfolio Table 107. Hansoh Pharma Recent Development Table 108. Hisun Pharmaceuticals Company Information Table 109. Hisun Pharmaceuticals Business Overview Table 110. Hisun Pharmaceuticals Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hisun Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio Table 112. Hisun Pharmaceuticals Recent Development Table 113. Furen Medicines Company Information Table 114. Furen Medicines Business Overview Table 115. Furen Medicines Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Furen Medicines Donepezil Hydrochloride Tablets Product Portfolio Table 117. Furen Medicines Recent Development Table 118. Disha Pharmaceutical Company Information Table 119. Disha Pharmaceutical Business Overview Table 120. Disha Pharmaceutical Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Disha Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio Table 122. Disha Pharmaceutical Recent Development Table 123. Zydus Company Information Table 124. Zydus Business Overview Table 125. Zydus Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Zydus Donepezil Hydrochloride Tablets Product Portfolio Table 127. Zydus Recent Development Table 128. Torrent Pharmaceuticals Company Information Table 129. Torrent Pharmaceuticals Business Overview Table 130. Torrent Pharmaceuticals Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Torrent Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio Table 132. Torrent Pharmaceuticals Recent Development Table 133. Strides Pharma Company Information Table 134. Strides Pharma Business Overview Table 135. Strides Pharma Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Strides Pharma Donepezil Hydrochloride Tablets Product Portfolio Table 137. Strides Pharma Recent Development Table 138. Macleods Pharmaceuticals Company Information Table 139. Macleods Pharmaceuticals Business Overview Table 140. Macleods Pharmaceuticals Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Macleods Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio Table 142. Macleods Pharmaceuticals Recent Development Table 143. Lupin Company Information Table 144. Lupin Business Overview Table 145. Lupin Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Lupin Donepezil Hydrochloride Tablets Product Portfolio Table 147. Lupin Recent Development Table 148. Hetero Company Information Table 149. Hetero Business Overview Table 150. Hetero Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Hetero Donepezil Hydrochloride Tablets Product Portfolio Table 152. Hetero Recent Development Table 153. Eisai Company Information Table 154. Eisai Business Overview Table 155. Eisai Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Eisai Donepezil Hydrochloride Tablets Product Portfolio Table 157. Eisai Recent Development Table 158. Dr. Reddy's Laboratories Company Information Table 159. Dr. Reddy's Laboratories Business Overview Table 160. Dr. Reddy's Laboratories Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Dr. Reddy's Laboratories Donepezil Hydrochloride Tablets Product Portfolio Table 162. Dr. Reddy's Laboratories Recent Development Table 163. Cipla Company Information Table 164. Cipla Business Overview Table 165. Cipla Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Cipla Donepezil Hydrochloride Tablets Product Portfolio Table 167. Cipla Recent Development Table 168. Chartwell Company Information Table 169. Chartwell Business Overview Table 170. Chartwell Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Chartwell Donepezil Hydrochloride Tablets Product Portfolio Table 172. Chartwell Recent Development Table 173. Cadila Pharmaceuticals Company Information Table 174. Cadila Pharmaceuticals Business Overview Table 175. Cadila Pharmaceuticals Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Cadila Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio Table 177. Cadila Pharmaceuticals Recent Development Table 178. Aurobindo Pharma Company Information Table 179. Aurobindo Pharma Business Overview Table 180. Aurobindo Pharma Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. Aurobindo Pharma Donepezil Hydrochloride Tablets Product Portfolio Table 182. Aurobindo Pharma Recent Development Table 183. Alembic Company Information Table 184. Alembic Business Overview Table 185. Alembic Donepezil Hydrochloride Tablets Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 186. Alembic Donepezil Hydrochloride Tablets Product Portfolio Table 187. Alembic Recent Development Table 188. Key Raw Materials Table 189. Raw Materials Key Suppliers Table 190. Donepezil Hydrochloride Tablets Distributors List Table 191. Donepezil Hydrochloride Tablets Customers List Table 192. Research Programs/Design for This Report Table 193. Authors List of This Report Table 194. Secondary Sources Table 195. Primary Sources List of Figures Figure 1. Donepezil Hydrochloride Tablets Product Image Figure 2. Global Donepezil Hydrochloride Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Donepezil Hydrochloride Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Donepezil Hydrochloride Tablets Sales (2021-2032) & (K Units) Figure 5. Global Donepezil Hydrochloride Tablets Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Donepezil Hydrochloride Tablets Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Orally Disintegrating Tablets Image Figure 9. Immediate-release Tablets Image Figure 10. Global Donepezil Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Donepezil Hydrochloride Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Donepezil Hydrochloride Tablets Sales Market Share by Type (2021-2032) Figure 13. Global Donepezil Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Donepezil Hydrochloride Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Donepezil Hydrochloride Tablets Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacy Image Figure 17. Hospital Pharmacy Image Figure 18. Online Pharmacy Image Figure 19. Global Donepezil Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Donepezil Hydrochloride Tablets Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Donepezil Hydrochloride Tablets Sales Market Share by Application (2021-2032) Figure 22. Global Donepezil Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Donepezil Hydrochloride Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Donepezil Hydrochloride Tablets Revenue Market Share by Application (2021-2032) Figure 25. North America Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Donepezil Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 27. U.S. Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Donepezil Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 32. Germany Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Donepezil Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 39. China Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Donepezil Hydrochloride Tablets Sales Market Share by Country (2021-2032) Figure 47. Brazil Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Donepezil Hydrochloride Tablets Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Donepezil Hydrochloride Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Donepezil Hydrochloride Tablets Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Donepezil Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 58. North America Donepezil Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Donepezil Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 60. Europe Donepezil Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Donepezil Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Donepezil Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Donepezil Hydrochloride Tablets Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Donepezil Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Donepezil Hydrochloride Tablets Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Donepezil Hydrochloride Tablets Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Orally Disintegrating Tablets
  • Immediate-release Tablets
Applications
  • Retail Pharmacy
  • Hospital Pharmacy
  • Online Pharmacy
Companies covered
  • Zein Biotechnology
  • Zhejiang Huahai Pharmaceutical
  • Yangtze River Pharmaceutical
  • Tianjin Lisheng Pharmaceutical
  • Sichuan Sunnyhope Pharmaceutical
  • Shaanxi Ark Pharmaceutical
  • Shandong Fangming Pharmaceutical
  • Goldensun Pharmaceutical
  • Hansoh Pharma
  • Hisun Pharmaceuticals
  • Furen Medicines
  • Disha Pharmaceutical
  • Zydus
  • Torrent Pharmaceuticals
  • Strides Pharma
  • Macleods Pharmaceuticals
  • Lupin
  • Hetero
  • Eisai
  • Dr. Reddy's Laboratories
  • Cipla
  • Chartwell
  • Cadila Pharmaceuticals
  • Aurobindo Pharma
  • Alembic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Donepezil Hydrochloride Tablets Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Donepezil Hydrochloride Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Donepezil Hydrochloride Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Donepezil Hydrochloride Tablets Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Donepezil Hydrochloride Tablets Market Dynamics
  1. 2.1 Donepezil Hydrochloride Tablets Industry Trends
  2. 2.2 Donepezil Hydrochloride Tablets Industry Drivers
  3. 2.3 Donepezil Hydrochloride Tablets Industry Opportunities and Challenges
  4. 2.4 Donepezil Hydrochloride Tablets Industry Restraints
3 Donepezil Hydrochloride Tablets Market by Manufacturers
  1. 3.1 Global Donepezil Hydrochloride Tablets Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Donepezil Hydrochloride Tablets Sales by Manufacturers (2021-2026)
  3. 3.3 Global Donepezil Hydrochloride Tablets Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Donepezil Hydrochloride Tablets Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Donepezil Hydrochloride Tablets Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Donepezil Hydrochloride Tablets Manufacturers, Product Type & Application
  7. 3.7 Global Donepezil Hydrochloride Tablets Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Donepezil Hydrochloride Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Donepezil Hydrochloride Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Donepezil Hydrochloride Tablets Tier 1, Tier 2, and Tier 3
4 Donepezil Hydrochloride Tablets Market by Type
  1. 4.1 Donepezil Hydrochloride Tablets Type Introduction
  2. 4.1.1 Orally Disintegrating Tablets
  3. 4.1.2 Immediate-release Tablets
  4. 4.2 Global Donepezil Hydrochloride Tablets Sales by Type
  5. 4.2.1 Global Donepezil Hydrochloride Tablets Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Donepezil Hydrochloride Tablets Sales by Type (2021-2032)
  7. 4.2.3 Global Donepezil Hydrochloride Tablets Sales Market Share by Type (2021-2032)
  8. 4.3 Global Donepezil Hydrochloride Tablets Revenue by Type
  9. 4.3.1 Global Donepezil Hydrochloride Tablets Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Donepezil Hydrochloride Tablets Revenue by Type (2021-2032)
  11. 4.3.3 Global Donepezil Hydrochloride Tablets Revenue Market Share by Type (2021-2032)
5 Donepezil Hydrochloride Tablets Market by Application
  1. 5.1 Donepezil Hydrochloride Tablets Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Hospital Pharmacy
  4. 5.1.3 Online Pharmacy
  5. 5.2 Global Donepezil Hydrochloride Tablets Sales by Application
  6. 5.2.1 Global Donepezil Hydrochloride Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Donepezil Hydrochloride Tablets Sales by Application (2021-2032)
  8. 5.2.3 Global Donepezil Hydrochloride Tablets Sales Market Share by Application (2021-2032)
  9. 5.3 Global Donepezil Hydrochloride Tablets Revenue by Application
  10. 5.3.1 Global Donepezil Hydrochloride Tablets Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Donepezil Hydrochloride Tablets Revenue by Application (2021-2032)
  12. 5.3.3 Global Donepezil Hydrochloride Tablets Revenue Market Share by Application (2021-2032)
6 Global Donepezil Hydrochloride Tablets Sales by Region
  1. 6.1 Global Donepezil Hydrochloride Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Donepezil Hydrochloride Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Donepezil Hydrochloride Tablets Sales by Region (2021-2026)
  4. 6.2.2 Global Donepezil Hydrochloride Tablets Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Donepezil Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Donepezil Hydrochloride Tablets Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Donepezil Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Donepezil Hydrochloride Tablets Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Donepezil Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Donepezil Hydrochloride Tablets Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Donepezil Hydrochloride Tablets Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Donepezil Hydrochloride Tablets Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Donepezil Hydrochloride Tablets Revenue by Region
  1. 7.1 Global Donepezil Hydrochloride Tablets Revenue by Region
  2. 7.1.1 Global Donepezil Hydrochloride Tablets Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Donepezil Hydrochloride Tablets Revenue by Region (2021-2026)
  4. 7.1.3 Global Donepezil Hydrochloride Tablets Revenue by Region (2027-2032)
  5. 7.1.4 Global Donepezil Hydrochloride Tablets Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Donepezil Hydrochloride Tablets Revenue (2021-2032)
  8. 7.2.2 North America Donepezil Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Donepezil Hydrochloride Tablets Revenue (2021-2032)
  11. 7.3.2 Europe Donepezil Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Donepezil Hydrochloride Tablets Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Donepezil Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Donepezil Hydrochloride Tablets Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Donepezil Hydrochloride Tablets Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zein Biotechnology
  2. 8.1.1 Zein Biotechnology Company Information
  3. 8.1.2 Zein Biotechnology Business Overview
  4. 8.1.3 Zein Biotechnology Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zein Biotechnology Donepezil Hydrochloride Tablets Product Portfolio
  6. 8.1.5 Zein Biotechnology Recent Developments
  7. 8.2 Zhejiang Huahai Pharmaceutical
  8. 8.2.1 Zhejiang Huahai Pharmaceutical Company Information
  9. 8.2.2 Zhejiang Huahai Pharmaceutical Business Overview
  10. 8.2.3 Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zhejiang Huahai Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  12. 8.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
  13. 8.3 Yangtze River Pharmaceutical
  14. 8.3.1 Yangtze River Pharmaceutical Company Information
  15. 8.3.2 Yangtze River Pharmaceutical Business Overview
  16. 8.3.3 Yangtze River Pharmaceutical Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Yangtze River Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  18. 8.3.5 Yangtze River Pharmaceutical Recent Developments
  19. 8.4 Tianjin Lisheng Pharmaceutical
  20. 8.4.1 Tianjin Lisheng Pharmaceutical Company Information
  21. 8.4.2 Tianjin Lisheng Pharmaceutical Business Overview
  22. 8.4.3 Tianjin Lisheng Pharmaceutical Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Tianjin Lisheng Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  24. 8.4.5 Tianjin Lisheng Pharmaceutical Recent Developments
  25. 8.5 Sichuan Sunnyhope Pharmaceutical
  26. 8.5.1 Sichuan Sunnyhope Pharmaceutical Company Information
  27. 8.5.2 Sichuan Sunnyhope Pharmaceutical Business Overview
  28. 8.5.3 Sichuan Sunnyhope Pharmaceutical Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sichuan Sunnyhope Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  30. 8.5.5 Sichuan Sunnyhope Pharmaceutical Recent Developments
  31. 8.6 Shaanxi Ark Pharmaceutical
  32. 8.6.1 Shaanxi Ark Pharmaceutical Company Information
  33. 8.6.2 Shaanxi Ark Pharmaceutical Business Overview
  34. 8.6.3 Shaanxi Ark Pharmaceutical Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shaanxi Ark Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  36. 8.6.5 Shaanxi Ark Pharmaceutical Recent Developments
  37. 8.7 Shandong Fangming Pharmaceutical
  38. 8.7.1 Shandong Fangming Pharmaceutical Company Information
  39. 8.7.2 Shandong Fangming Pharmaceutical Business Overview
  40. 8.7.3 Shandong Fangming Pharmaceutical Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shandong Fangming Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  42. 8.7.5 Shandong Fangming Pharmaceutical Recent Developments
  43. 8.8 Goldensun Pharmaceutical
  44. 8.8.1 Goldensun Pharmaceutical Company Information
  45. 8.8.2 Goldensun Pharmaceutical Business Overview
  46. 8.8.3 Goldensun Pharmaceutical Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Goldensun Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  48. 8.8.5 Goldensun Pharmaceutical Recent Developments
  49. 8.9 Hansoh Pharma
  50. 8.9.1 Hansoh Pharma Company Information
  51. 8.9.2 Hansoh Pharma Business Overview
  52. 8.9.3 Hansoh Pharma Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hansoh Pharma Donepezil Hydrochloride Tablets Product Portfolio
  54. 8.9.5 Hansoh Pharma Recent Developments
  55. 8.10 Hisun Pharmaceuticals
  56. 8.10.1 Hisun Pharmaceuticals Company Information
  57. 8.10.2 Hisun Pharmaceuticals Business Overview
  58. 8.10.3 Hisun Pharmaceuticals Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hisun Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio
  60. 8.10.5 Hisun Pharmaceuticals Recent Developments
  61. 8.11 Furen Medicines
  62. 8.11.1 Furen Medicines Company Information
  63. 8.11.2 Furen Medicines Business Overview
  64. 8.11.3 Furen Medicines Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Furen Medicines Donepezil Hydrochloride Tablets Product Portfolio
  66. 8.11.5 Furen Medicines Recent Developments
  67. 8.12 Disha Pharmaceutical
  68. 8.12.1 Disha Pharmaceutical Company Information
  69. 8.12.2 Disha Pharmaceutical Business Overview
  70. 8.12.3 Disha Pharmaceutical Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Disha Pharmaceutical Donepezil Hydrochloride Tablets Product Portfolio
  72. 8.12.5 Disha Pharmaceutical Recent Developments
  73. 8.13 Zydus
  74. 8.13.1 Zydus Company Information
  75. 8.13.2 Zydus Business Overview
  76. 8.13.3 Zydus Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Zydus Donepezil Hydrochloride Tablets Product Portfolio
  78. 8.13.5 Zydus Recent Developments
  79. 8.14 Torrent Pharmaceuticals
  80. 8.14.1 Torrent Pharmaceuticals Company Information
  81. 8.14.2 Torrent Pharmaceuticals Business Overview
  82. 8.14.3 Torrent Pharmaceuticals Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Torrent Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio
  84. 8.14.5 Torrent Pharmaceuticals Recent Developments
  85. 8.15 Strides Pharma
  86. 8.15.1 Strides Pharma Company Information
  87. 8.15.2 Strides Pharma Business Overview
  88. 8.15.3 Strides Pharma Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Strides Pharma Donepezil Hydrochloride Tablets Product Portfolio
  90. 8.15.5 Strides Pharma Recent Developments
  91. 8.16 Macleods Pharmaceuticals
  92. 8.16.1 Macleods Pharmaceuticals Company Information
  93. 8.16.2 Macleods Pharmaceuticals Business Overview
  94. 8.16.3 Macleods Pharmaceuticals Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Macleods Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio
  96. 8.16.5 Macleods Pharmaceuticals Recent Developments
  97. 8.17 Lupin
  98. 8.17.1 Lupin Company Information
  99. 8.17.2 Lupin Business Overview
  100. 8.17.3 Lupin Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Lupin Donepezil Hydrochloride Tablets Product Portfolio
  102. 8.17.5 Lupin Recent Developments
  103. 8.18 Hetero
  104. 8.18.1 Hetero Company Information
  105. 8.18.2 Hetero Business Overview
  106. 8.18.3 Hetero Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Hetero Donepezil Hydrochloride Tablets Product Portfolio
  108. 8.18.5 Hetero Recent Developments
  109. 8.19 Eisai
  110. 8.19.1 Eisai Company Information
  111. 8.19.2 Eisai Business Overview
  112. 8.19.3 Eisai Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Eisai Donepezil Hydrochloride Tablets Product Portfolio
  114. 8.19.5 Eisai Recent Developments
  115. 8.20 Dr. Reddy's Laboratories
  116. 8.20.1 Dr. Reddy's Laboratories Company Information
  117. 8.20.2 Dr. Reddy's Laboratories Business Overview
  118. 8.20.3 Dr. Reddy's Laboratories Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Dr. Reddy's Laboratories Donepezil Hydrochloride Tablets Product Portfolio
  120. 8.20.5 Dr. Reddy's Laboratories Recent Developments
  121. 8.21 Cipla
  122. 8.21.1 Cipla Company Information
  123. 8.21.2 Cipla Business Overview
  124. 8.21.3 Cipla Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Cipla Donepezil Hydrochloride Tablets Product Portfolio
  126. 8.21.5 Cipla Recent Developments
  127. 8.22 Chartwell
  128. 8.22.1 Chartwell Company Information
  129. 8.22.2 Chartwell Business Overview
  130. 8.22.3 Chartwell Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Chartwell Donepezil Hydrochloride Tablets Product Portfolio
  132. 8.22.5 Chartwell Recent Developments
  133. 8.23 Cadila Pharmaceuticals
  134. 8.23.1 Cadila Pharmaceuticals Company Information
  135. 8.23.2 Cadila Pharmaceuticals Business Overview
  136. 8.23.3 Cadila Pharmaceuticals Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Cadila Pharmaceuticals Donepezil Hydrochloride Tablets Product Portfolio
  138. 8.23.5 Cadila Pharmaceuticals Recent Developments
  139. 8.24 Aurobindo Pharma
  140. 8.24.1 Aurobindo Pharma Company Information
  141. 8.24.2 Aurobindo Pharma Business Overview
  142. 8.24.3 Aurobindo Pharma Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Aurobindo Pharma Donepezil Hydrochloride Tablets Product Portfolio
  144. 8.24.5 Aurobindo Pharma Recent Developments
  145. 8.25 Alembic
  146. 8.25.1 Alembic Company Information
  147. 8.25.2 Alembic Business Overview
  148. 8.25.3 Alembic Donepezil Hydrochloride Tablets Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Alembic Donepezil Hydrochloride Tablets Product Portfolio
  150. 8.25.5 Alembic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Donepezil Hydrochloride Tablets Value Chain Analysis
  2. 9.1.1 Donepezil Hydrochloride Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Donepezil Hydrochloride Tablets Production Mode & Process
  6. 9.2 Donepezil Hydrochloride Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Donepezil Hydrochloride Tablets Distributors
  9. 9.2.3 Donepezil Hydrochloride Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst